DNA-intercalating antiphage molecules trigger abortive infection through mutual destruction and synergize with bacterial immunity

• 成果类型: Article
• 署名作者: Ernst, Larissa; Gatgens, Cornelia; Rackow, Bente; Pozhydaieva, Nadiia; Gaaloul, Elyes; Kruger, Aileen; Seiffarth, Johannes; Bund, Michelle; Joisten-Rosenthal, Vivien; Kohlheyer, Dietrich; Usadel, Bjorn; Harms, Alexander; Hofer, Katharina; Frunzke, Julia
• 署名单位: Helmholtz Association; Julich Research Centre; Heinrich Heine University Dusseldorf; Max Planck Society; Philipps University Marburg; Heinrich Heine University Dusseldorf; Helmholtz Association; Julich Research Centre; Swiss Federal Institutes of Technology Domain; ETH Zurich; Philipps University Marburg
• 刊物名称: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
• ISSN/ISSBN: 0027-8424; 1091-6490
• DOI: 10.1073/pnas.2602073123
• 发表日期: 2026-06-09
• 页码: e2602073123
• 关键词: bacteriophage; bacterial immunity; phage defense; daunorubicin; T5; DEFENSE

摘要

Bacteria deploy diverse antiphage defense systems, including small bioactive molecules providing protection at the multicellular level. DNA-intercalating anthracyclines, such as daunorubicin, exhibit broad antiphage activity, but the underlying mechanism has remained elusive. Here, we systematically screened the Escherichia coli BASEL phage collection to elucidate the mode of action of DNA-intercalating antiphage molecules. We identified taxonomically distinct clusters of susceptible viral groups and show that for the Tequintavirus Bas33 (Markadamsvirinae), daunorubicin blocks infection after first-step transfer. In the presence of daunorubicin, continued expression of pre-early genes leads to abortive infection via mutual destruction, where both phage and host succumb. Analogous abortive-infection phenotypes occur across taxonomically diverse phages exposed to chemically distinct DNA-intercalating molecules. Notably, we show that daunorubicin synergizes with downstream nucleic acid-targeting defenses underscoring context-dependent outcomes. Together, these findings reveal how chemical defense contributes to the multilayered antiviral immunity and highlight the intricate interplay between mechanistic inhibition and infection outcome.